Wine Polyphenols and Neurodegenerative Diseases: An Update on the Molecular Mechanisms Underpinning Their Protective Effects
暂无分享,去创建一个
[1] M. Zahran,et al. Novel multi-target compounds in the quest for new chemotherapies against Alzheimer's disease: An experimental and theoretical study. , 2018, Bioorganic & medicinal chemistry.
[2] M. Prata-Sena,et al. The terroir of Port wine: Two hundred and sixty years of history. , 2018, Food chemistry.
[3] M. Pallàs,et al. Resveratrol Induces Brain Resilience Against Alzheimer Neurodegeneration Through Proteostasis Enhancement , 2018, Molecular Neurobiology.
[4] E. Sigurdsson,et al. Tau-targeting therapies for Alzheimer disease , 2018, Nature Reviews Neurology.
[5] F. Stefanello,et al. Anthocyanins as a potential pharmacological agent to manage memory deficit, oxidative stress and alterations in ion pump activity induced by experimental sporadic dementia of Alzheimer's type. , 2018, The Journal of nutritional biochemistry.
[6] T. Matsumiya,et al. Gnetin C, a resveratrol dimer, reduces amyloid-β 1-42 (Aβ42) production and ameliorates Aβ42-lowered cell viability in cultured SH-SY5Y human neuroblastoma cells. , 2018, Biomedical research.
[7] Jing Zhang,et al. Resveratrol Suppresses Rotenone‐induced Neurotoxicity Through Activation of SIRT1/Akt1 Signaling Pathway , 2018, Anatomical record.
[8] S. Berndt,et al. The association of lifetime alcohol use with mortality and cancer risk in older adults: A cohort study , 2018, PLoS medicine.
[9] M. Hornberger,et al. Impact of Flavonoids on Cellular and Molecular Mechanisms Underlying Age-Related Cognitive Decline and Neurodegeneration , 2018, Current Nutrition Reports.
[10] A. Muthuraman,et al. Therapeutic evaluation of solid lipid nanoparticle of quercetin in pentylenetetrazole induced cognitive impairment of zebrafish , 2018, Life sciences.
[11] D. Lie,et al. Insulin-like Growth Factor 1 (IGF-1) as a marker of cognitive decline in normal ageing: A review , 2018, Ageing Research Reviews.
[12] Berislav V. Zlokovic,et al. Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders , 2018, Nature Reviews Neurology.
[13] M. Landgraf,et al. Regulation of neuronal development and function by ROS , 2018, FEBS letters.
[14] Jie Xu,et al. Quercetin inhibits okadaic acid-induced tau protein hyperphosphorylation through the Ca2+‑calpain‑p25‑CDK5 pathway in HT22 cells. , 2017, International journal of molecular medicine.
[15] B. Barres,et al. Microglia and macrophages in brain homeostasis and disease , 2017, Nature Reviews Immunology.
[16] Hee-Sun Kim,et al. Resveratrol Ameliorates Tau Hyperphosphorylation at Ser396 Site and Oxidative Damage in Rat Hippocampal Slices Exposed to Vanadate: Implication of ERK1/2 and GSK-3β Signaling Cascades. , 2017, Journal of agricultural and food chemistry.
[17] S. Réhman,et al. Anthocyanin-Loaded PEG-Gold Nanoparticles Enhanced the Neuroprotection of Anthocyanins in an Aβ1–42 Mouse Model of Alzheimer’s Disease , 2016, Molecular Neurobiology.
[18] F. Shahidi,et al. Lipophilization of Resveratrol and Effects on Antioxidant Activities. , 2017, Journal of agricultural and food chemistry.
[19] Jinbo Cheng,et al. Vitamin D Combined with Resveratrol Prevents Cognitive Decline in SAMP8 Mice. , 2017, Current Alzheimer research.
[20] Puneet Kumar,et al. Neuroprotective potential of Quercetin in combination with piperine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity , 2017, Neural regeneration research.
[21] Ilya Bezprozvanny,et al. Calcium signaling and molecular mechanisms underlying neurodegenerative diseases. , 2017, Cell calcium.
[22] M. Kawahara,et al. Cross talk between neurometals and amyloidogenic proteins at the synapse and the pathogenesis of neurodegenerative diseases. , 2017, Metallomics : integrated biometal science.
[23] A. Kanthasamy,et al. Molecular mechanisms underlying protective effects of quercetin against mitochondrial dysfunction and progressive dopaminergic neurodegeneration in cell culture and MitoPark transgenic mouse models of Parkinson's Disease , 2017, Journal of neurochemistry.
[24] C. Isidoro,et al. Resveratrol protects neuronal-like cells expressing mutant Huntingtin from dopamine toxicity by rescuing ATG4-mediated autophagosome formation , 2017, Neurochemistry International.
[25] M. Maeda,et al. Combination therapy with octyl gallate and ferulic acid improves cognition and neurodegeneration in a transgenic mouse model of Alzheimer's disease , 2017, The Journal of Biological Chemistry.
[26] O. Franco,et al. Alcoholic beverage preference and diabetes incidence across Europe: the Consortium on Health and Ageing Network of Cohorts in Europe and the United States (CHANCES) project , 2017, European Journal of Clinical Nutrition.
[27] M. Kim,et al. Anthocyanins encapsulated by PLGA@PEG nanoparticles potentially improved its free radical scavenging capabilities via p38/JNK pathway against Aβ1–42-induced oxidative stress , 2017, Journal of Nanobiotechnology.
[28] R. He,et al. Resveratrol Attenuates Formaldehyde Induced Hyperphosphorylation of Tau Protein and Cytotoxicity in N2a Cells , 2017, Frontiers in neuroscience.
[29] F. J. Luque,et al. Combined in Vitro Cell-Based/in Silico Screening of Naturally Occurring Flavonoids and Phenolic Compounds as Potential Anti-Alzheimer Drugs. , 2017, Journal of natural products.
[30] L. Tan,et al. Alcohol consumption and dementia risk: a dose–response meta-analysis of prospective studies , 2017, European Journal of Epidemiology.
[31] G. Gao,et al. Resveratrol attenuates MPP+-induced mitochondrial dysfunction and cell apoptosis via AKT/GSK-3β pathway in SN4741 cells , 2017, Neuroscience Letters.
[32] M. Islam. Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders , 2017, Neurological research.
[33] S. Salim,et al. Oxidative Stress and the Central Nervous System , 2017, The Journal of Pharmacology and Experimental Therapeutics.
[34] S. Martín-Aragón,et al. Neurohormetic responses of quercetin and rutin in a cell line over-expressing the amyloid precursor protein (APPswe cells). , 2016, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[35] P. Mcgeer,et al. Quercetin, not caffeine, is a major neuroprotective component in coffee , 2016, Neurobiology of Aging.
[36] S. Kuo,et al. Resveratrol alleviates MPTP-induced motor impairments and pathological changes by autophagic degradation of α-synuclein via SIRT1-deacetylated LC3. , 2016, Molecular nutrition & food research.
[37] Siming Huang,et al. Effects of grape seed proanthocyanidin on Alzheimer's disease in vitro and in vivo , 2016, Experimental and therapeutic medicine.
[38] H. El-Horany,et al. Ameliorative Effect of Quercetin on Neurochemical and Behavioral Deficits in Rotenone Rat Model of Parkinson's Disease: Modulating Autophagy (Quercetin on Experimental Parkinson's Disease) , 2016, Journal of biochemical and molecular toxicology.
[39] Haoyue Deng,et al. Resveratrol Attenuates Aβ25–35 Caused Neurotoxicity by Inducing Autophagy Through the TyrRS-PARP1-SIRT1 Signaling Pathway , 2016, Neurochemical Research.
[40] M. Elbatsh,et al. Modulatory effects of resveratrol on endoplasmic reticulum stress-associated apoptosis and oxido-inflammatory markers in a rat model of rotenone-induced Parkinson's disease. , 2016, Chemico-biological interactions.
[41] Weilang Li,et al. NAMPT protects against 6-hydroxydopamine-induced neurotoxicity in PC12 cells through modulating SIRT1 activity. , 2016, Molecular medicine reports.
[42] Min-Ju Kim,et al. Piceatannol, a natural analogue of resveratrol, effectively reduces beta-amyloid levels via activation of alpha-secretase and matrix metalloproteinase-9 , 2016 .
[43] J. Hardy,et al. The amyloid hypothesis of Alzheimer's disease at 25 years , 2016, EMBO molecular medicine.
[44] F. Mahn,et al. Resveratrol reduces amyloid-beta (Aβ1–42)-induced paralysis through targeting proteostasis in an Alzheimer model of Caenorhabditis elegans , 2016, European Journal of Nutrition.
[45] Jing Zhang,et al. Resveratrol Protects PC12 Cell against 6-OHDA Damage via CXCR4 Signaling Pathway , 2015, Evidence-based complementary and alternative medicine : eCAM.
[46] Jia-wei Zhou,et al. Neuroinflammation in Parkinson’s disease and its potential as therapeutic target , 2015, Translational Neurodegeneration.
[47] J. Blesa,et al. Oxidative stress and Parkinson’s disease , 2015, Front. Neuroanat..
[48] B. Jeon,et al. The role of quercetin on the survival of neuron-like PC12 cells and the expression of α-synuclein , 2015, Neural regeneration research.
[49] J. R. Ramírez-Pineda,et al. The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model mice , 2015, Neuropharmacology.
[50] Muralidhara,et al. Combined Oral Supplementation of Fish Oil and Quercetin Enhances Neuroprotection in a Chronic Rotenone Rat Model: Relevance to Parkinson’s Disease , 2015, Neurochemical Research.
[51] T. Broderick,et al. Resveratrol protects β amyloid-induced oxidative damage and memory associated proteins in H19-7 hippocampal neuronal cells. , 2015, Current Alzheimer research.
[52] Huaxi Xu,et al. The Resveratrol Trimer Miyabenol C Inhibits β-Secretase Activity and β-Amyloid Generation , 2015, PloS one.
[53] J. Richardson,et al. Dietary (−)-epicatechin as a potent inhibitor of βγ-secretase amyloid precursor protein processing , 2015, Neurobiology of Aging.
[54] D. Selkoe,et al. Purification of α-Synuclein from Human Brain Reveals an Instability of Endogenous Multimers as the Protein Approaches Purity , 2014, Biochemistry.
[55] W. V. Van Nostrand,et al. Capping of Aβ42 Oligomers by Small Molecule Inhibitors , 2014, Biochemistry.
[56] A. Meratan,et al. Interaction of Aβ(25–35) fibrillation products with mitochondria: Effect of small‐molecule natural products , 2014, Biopolymers.
[57] Byeong-Chae Kim,et al. Effects of Flavonoid Compounds on β-amyloid-peptide-induced Neuronal Death in Cultured Mouse Cortical Neurons , 2014, Chonnam medical journal.
[58] Vincenzo Bonifati,et al. Effect of resveratrol on mitochondrial function: implications in parkin-associated familiar Parkinson's disease. , 2014, Biochimica et biophysica acta.
[59] Dong-mei Wang,et al. Effects of Long-Term Treatment with Quercetin on Cognition and Mitochondrial Function in a Mouse Model of Alzheimer’s Disease , 2014, Neurochemical Research.
[60] D. Eliezer,et al. Structure activity relationship of phenolic acid inhibitors of α-synuclein fibril formation and toxicity , 2014, Front. Aging Neurosci..
[61] F. Fan,et al. Radioprotective and Antioxidant Effect of Resveratrol in Hippocampus by Activating Sirt1 , 2014, International journal of molecular sciences.
[62] Shang-Der Chen,et al. Resveratrol Partially Prevents Rotenone-Induced Neurotoxicity in Dopaminergic SH-SY5Y Cells through Induction of Heme Oxygenase-1 Dependent Autophagy , 2014, International journal of molecular sciences.
[63] D. Galimberti,et al. Immunotherapy against amyloid pathology in Alzheimer's disease , 2013, Journal of the Neurological Sciences.
[64] G. Casadesus,et al. Dietary resveratrol prevents Alzheimer’s markers and increases life span in SAMP8 , 2013, AGE.
[65] G. Viana,et al. Catechin attenuates behavioral neurotoxicity induced by 6-OHDA in rats , 2013, Pharmacology Biochemistry and Behavior.
[66] M. Delgado,et al. Neuroprotective Properties of Standardized Extracts of Hypericum perforatum on Rotenone Model of Parkinson's Disease. , 2013, CNS & neurological disorders drug targets.
[67] M. Chesselet,et al. Mitochondrial dysfunction and oxidative stress in Parkinson's disease , 2013, Progress in Neurobiology.
[68] M. Mansouri,et al. Neuroprotective effects of oral gallic acid against oxidative stress induced by 6-hydroxydopamine in rats. , 2013, Food chemistry.
[69] S. Karuppagounder,et al. Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson’s disease in rats , 2013, Neuroscience.
[70] Min Zhu,et al. Oxidized quercetin inhibits α-synuclein fibrillization. , 2013, Biochimica et biophysica acta.
[71] R. Pi,et al. Protective effects of caffeic acid and caffeic acid phenethyl ester against acrolein-induced neurotoxicity in HT22 mouse hippocampal cells , 2013, Neuroscience Letters.
[72] M. Guillot-Sestier,et al. Ferulic Acid Is a Nutraceutical β-Secretase Modulator That Improves Behavioral Impairment and Alzheimer-like Pathology in Transgenic Mice , 2013, PloS one.
[73] Nagaraja Haleagrahara,et al. Effect of quercetin and desferrioxamine on 6-hydroxydopamine (6-OHDA) induced neurotoxicity in striatum of rats. , 2013, The Journal of toxicological sciences.
[74] J. Simon,et al. Identification of brain‐targeted bioactive dietary quercetin‐3‐O‐glucuronide as a novel intervention for Alzheimer's disease , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[75] H. Byun,et al. β-secretase inhibitory activity of phenolic acid conjugated chitooligosaccharides , 2013, Journal of enzyme inhibition and medicinal chemistry.
[76] A. Wimo,et al. The global prevalence of dementia: A systematic review and metaanalysis , 2013, Alzheimer's & Dementia.
[77] K. Shindler,et al. SIRT1 activating compounds reduce oxidative stress and prevent cell death in neuronal cells , 2012, Front. Cell. Neurosci..
[78] Jiang-Ning Zhou,et al. The binding of resveratrol to monomer and fibril amyloid beta , 2012, Neurochemistry International.
[79] Weikai He,et al. Resveratrol attenuates oxidative damage and ameliorates cognitive impairment in the brain of senescence-accelerated mice. , 2012, Life sciences.
[80] M. Saraiva,et al. Stability of the Transthyretin Molecule as a Key Factor in the Interaction with A-Beta Peptide - Relevance in Alzheimer's Disease , 2012, PloS one.
[81] N. Belluardo,et al. Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson’s disease , 2012, Cellular and Molecular Life Sciences.
[82] K. Kawabata,et al. Effect of quercetin and its glucuronide metabolite upon 6-hydorxydopamine-induced oxidative damage in Neuro-2a cells , 2012, Free radical research.
[83] K. Lu,et al. Resveratrol Protects Rats from Aβ-induced Neurotoxicity by the Reduction of iNOS Expression and Lipid Peroxidation , 2011, PloS one.
[84] S. Martín-Aragón,et al. Quercetin and rutin exhibit antiamyloidogenic and fibril-disaggregating effects in vitro and potent antioxidant activity in APPswe cells. , 2011, Life sciences.
[85] H. Kurihara,et al. Resveratrol improves cognitive function in mice by increasing production of insulin-like growth factor-I in the hippocampus. , 2011, The Journal of nutritional biochemistry.
[86] N. Mitra,et al. Neuroprotective effect of bioflavonoid quercetin in 6-hydroxydopamine-induced oxidative stress biomarkers in the rat striatum , 2011, Neuroscience Letters.
[87] X. Pu,et al. Neuroprotective effect of kaempferol against a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease. , 2011, Biological & pharmaceutical bulletin.
[88] J. Jankovic,et al. Resveratrol-Activated AMPK/SIRT1/Autophagy in Cellular Models of Parkinson's Disease , 2011, Neurosignals.
[89] Sanjay Kumar,et al. Conformational transition in the substrate binding domain of β-secretase exploited by NMA and its implication in inhibitor recognition: BACE1–myricetin a case study , 2011, Neurochemistry International.
[90] S. Ryu,et al. In vitro BACE-1 inhibitory activity of resveratrol oligomers from the seed extract of Paeonia lactiflora. , 2011, Planta medica.
[91] G. Yen,et al. Protective effects of anthocyanins against amyloid β-peptide-induced damage in neuro-2A cells. , 2011, Journal of agricultural and food chemistry.
[92] S. Lichtenthaler. Alpha‐secretase in Alzheimer’s disease: molecular identity, regulation and therapeutic potential , 2011, Journal of neurochemistry.
[93] Dong-Mei Wu,et al. Quercetin activates AMP‐activated protein kinase by reducing PP2C expression protecting old mouse brain against high cholesterol‐induced neurotoxicity , 2010, The Journal of pathology.
[94] F. Zhang,et al. Resveratrol Protects Dopamine Neurons Against Lipopolysaccharide-Induced Neurotoxicity through Its Anti-Inflammatory Actions , 2010, Molecular Pharmacology.
[95] K. Kwon,et al. Melatonin Potentiates the Neuroprotective Properties of Resveratrol Against Beta-Amyloid-Induced Neurodegeneration by Modulating AMP-Activated Protein Kinase Pathways , 2010, Journal of clinical neurology.
[96] Dr David Vauzour,et al. Caffeic acid, tyrosol and p-coumaric acid are potent inhibitors of 5-S-cysteinyl-dopamine induced neurotoxicity. , 2010, Archives of biochemistry and biophysics.
[97] S. Rajasankar,et al. Resveratrol attenuates oxidative stress and improves behaviour in 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) challenged mice , 2010, Annals of neurosciences.
[98] R. Koehler,et al. Resveratrol protects against experimental stroke: Putative neuroprotective role of heme oxygenase 1 , 2010, Experimental Neurology.
[99] Soahary Andriamanarivo,et al. New stilbene dimers against amyloid fibril formation. , 2010, Bioorganic & medicinal chemistry letters.
[100] J. Dordick,et al. Resveratrol Selectively Remodels Soluble Oligomers and Fibrils of Amyloid Aβ into Off-pathway Conformers* , 2010, The Journal of Biological Chemistry.
[101] S. Costanzo,et al. Contemporary Reviews in Cardiovascular Medicine Cardiovascular and Overall Mortality Risk in Relation to Alcohol Consumption in Patients With Cardiovascular Disease , 2010 .
[102] T. Ishrat,et al. Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease , 2010, Brain Research.
[103] M. Kobori,et al. Autophagy impairment stimulates PS1 expression and γ-secretase activity , 2010, Autophagy.
[104] G. Rimbach,et al. Effect of dietary quercetin on brain quercetin levels and the expression of antioxidant and Alzheimer's disease relevant genes in mice. , 2010, Pharmacological research.
[105] M. Jimenez-Del-Rio,et al. The Effects of Polyphenols on Survival and Locomotor Activity in Drosophila melanogaster Exposed to Iron and Paraquat , 2010, Neurochemical Research.
[106] J. Simon,et al. AMP-activated Protein Kinase Signaling Activation by Resveratrol Modulates Amyloid-β Peptide Metabolism* , 2010, The Journal of Biological Chemistry.
[107] Lijuan Sun,et al. Grape extract protects mitochondria from oxidative damage and improves locomotor dysfunction and extends lifespan in a Drosophila Parkinson's disease model. , 2009, Rejuvenation research.
[108] Lei Huang,et al. Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation. , 2009, Neurotoxicology.
[109] M. Shimoji,et al. CXCR4 and CXCL12 Expression is Increased in the Nigro-Striatal System of Parkinson’s Disease , 2009, Neurotoxicity Research.
[110] Dagmar Verbaan,et al. Non-motor symptoms in Parkinson's disease , 2009 .
[111] S. Joo,et al. Protective effect of caffeic acid against beta-amyloid-induced neurotoxicity by the inhibition of calcium influx and tau phosphorylation. , 2009, Life sciences.
[112] M. Beal,et al. Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease , 2009, Neurochemistry International.
[113] S. Ryu,et al. A new specific BACE-1 inhibitor from the stembark extract of Vitis vinifera. , 2009, Planta medica.
[114] Qin Wu,et al. Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats. , 2008, European journal of pharmacology.
[115] K. Vafeiadou,et al. The neuroprotective potential of flavonoids: a multiplicity of effects , 2008, Genes & Nutrition.
[116] F. Sallusto,et al. Chemokines and leukocyte traffic , 2008, Nature Immunology.
[117] A. Raasmaja,et al. Time-dependent protective and harmful effects of quercetin on 6-OHDA-induced toxicity in neuronal SH-SY5Y cells. , 2008, Toxicology.
[118] K. Vafeiadou,et al. Peroxynitrite induced formation of the neurotoxins 5-S-cysteinyl-dopamine and DHBT-1: implications for Parkinson's disease and protection by polyphenols. , 2008, Archives of biochemistry and biophysics.
[119] K. Lu,et al. Neuroprotective effects of resveratrol on MPTP-induced neuron loss mediated by free radical scavenging. , 2008, Journal of agricultural and food chemistry.
[120] G. Bronchti,et al. Resveratrol, a red wine polyphenol, protects dopaminergic neurons in MPTP-treated mice , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[121] D. Teplow,et al. Grape-Derived Polyphenolics Prevent Aβ Oligomerization and Attenuate Cognitive Deterioration in a Mouse Model of Alzheimer's Disease , 2008, The Journal of Neuroscience.
[122] T. Kihara,et al. Flavonols and flavones as BACE-1 inhibitors: structure-activity relationship in cell-free, cell-based and in silico studies reveal novel pharmacophore features. , 2008, Biochimica et biophysica acta.
[123] A. Raasmaja,et al. Lack of robust protective effect of quercetin in two types of 6-hydroxydopamine-induced parkinsonian models in rats and dopaminergic cell cultures , 2008, Brain Research.
[124] C. Björkelund,et al. Alcoholic beverages and incidence of dementia: 34-year follow-up of the prospective population study of women in Goteborg. , 2007, American journal of epidemiology.
[125] Andre Fischer,et al. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis , 2007, The EMBO journal.
[126] M. Poncz,et al. Resveratrol protects SH-SY5Y neuroblastoma cells from apoptosis induced by dopamine , 2007, Experimental & Molecular Medicine.
[127] J. Milbrandt,et al. Resveratrol stimulates AMP kinase activity in neurons , 2007, Proceedings of the National Academy of Sciences.
[128] K. Vafeiadou,et al. Champagne wine polyphenols protect primary cortical neurons against peroxynitrite-induced injury. , 2007, Journal of agricultural and food chemistry.
[129] Phillip Nagley,et al. Rotenone and MPP+ preferentially redistribute apoptosis-inducing factor in apoptotic dopamine neurons , 2007, Neuroreport.
[130] A. Akaike,et al. Resveratrol protects dopaminergic neurons in midbrain slice culture from multiple insults. , 2007, Biochemical pharmacology.
[131] Jun Wang,et al. Moderate consumption of Cabernet Sauvignon attenuates A� neuropathology in a mouse model of Alzheimer's disease , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[132] Peter Davies,et al. Resveratrol Promotes Clearance of Alzheimer's Disease Amyloid-β Peptides* , 2005, Journal of Biological Chemistry.
[133] H. Dodge,et al. Alcohol consumption and cognitive function in late life , 2005, Neurology.
[134] R. Torella,et al. Red wine consumption improves insulin resistance but not endothelial function in type 2 diabetic patients. , 2005, Metabolism: clinical and experimental.
[135] R. Tanzi,et al. Twenty Years of the Alzheimer’s Disease Amyloid Hypothesis: A Genetic Perspective , 2005, Cell.
[136] R. Langer,et al. Association between reported alcohol intake and cognition: results from the Women's Health Initiative Memory Study. , 2005, American journal of epidemiology.
[137] F. Grodstein,et al. Effects of moderate alcohol consumption on cognitive function in women. , 2005, The New England journal of medicine.
[138] D. Dexter,et al. Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease , 2005, Free radical research.
[139] H. Vainio,et al. Wine and resveratrol: mechanisms of cancer prevention? , 2003, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[140] R. Nussbaum,et al. Alzheimer's disease and Parkinson's disease. , 2003, The New England journal of medicine.
[141] R. Quirion,et al. Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide‐related toxicity in cultured hippocampal neurons , 2000, British journal of pharmacology.
[142] T. Peng,et al. Mitochondrial dysfunction in Parkinson's disease. , 1999, Biochemical Society symposium.
[143] D Commenges,et al. Illustration of analysis taking into account complex survey considerations: the association between wine consumption and dementia in the PAQUID study. Personnes Ages Quid. , 1998, American journal of epidemiology.
[144] B. Draczynska-Lusiak,et al. Oxidized lipoproteins activate NF‐κB binding activity and apoptosis in PC12 cells , 1998, Neuroreport.
[145] C. Sempos,et al. Alcohol consumption and coronary heart disease morbidity and mortality. , 1997, American journal of epidemiology.
[146] D. Commenges,et al. Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. , 1997, Revue neurologique.
[147] M. Salama,et al. Effects of Exercise and Ferulic Acid on Alpha Synuclein and Neuroprotective Heat Shock Protein 70 in An Experimental Model of Parkinsonism Disease. , 2019, CNS & neurological disorders drug targets.
[148] J. Volkmann,et al. Parkinson disease , 2017, Nature Reviews Disease Primers.
[149] A. Naeem,et al. Anti-fibrillation potency of caffeic acid against an antidepressant induced fibrillogenesis of human α-synuclein: Implications for Parkinson's disease. , 2015, Biochimie.
[150] V. Andrisano,et al. Surface plasmon resonance, fluorescence, and circular dichroism studies for the characterization of the binding of BACE-1 inhibitors , 2012, Analytical and Bioanalytical Chemistry.
[151] T. Kihara,et al. Multifunction of myricetin on A beta: neuroprotection via a conformational change of A beta and reduction of A beta via the interference of secretases. , 2008, Journal of neuroscience research.
[152] M. Sawada,et al. Molecular mechanism of the relation of monoamine oxidase B and its inhibitors to Parkinson's disease: possible implications of glial cells. , 2006, Journal of neural transmission. Supplementum.
[153] L. Letenneur. Risk of dementia and alcohol and wine consumption: a review of recent results. , 2004, Biological research.
[154] E. Seifritz,et al. Red wine ingredient resveratrol protects from beta-amyloid neurotoxicity. , 2003, Gerontology.
[155] M G Spillantini,et al. Alpha-synuclein in Lewy bodies. , 1997, Nature.